Back to search
FDAFDA · Food and drugs·Recall number D-1338-2022

Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

Published July 27, 2022 · Recall initiated: June 27, 2022

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What to do

Voluntary: Firm initiated · Press Release

Recall details

Manufacturer
Loud Muscle Science
Distributor
The product was distributed nationwide in the USA and Canada.
Lot
Lot # 2022104, exp. date 04/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card